Valencia Nutrition Jumps Over 9% After Subsidiary Signs Manufacturing Deal with Virchow
Synopsis: Valencia Beverages and Superwaters Private Limited, a wholly owned subsidiary of Valencia Nutrition Limited, has entered into a strategic manufacturing agreement with Virchow Laboratories Limited for the production of its juice product portfolio. The deal, announced on April 6, 2026, covers 8 SKUs across key fruit variants and is aimed at accelerating production efficiency […] The post Valencia Nutrition Jumps Over 9% After Subsidiary Signs Manufacturing Deal with Virchow appeared first on Trade Brains.
Synopsis: Valencia Beverages and Superwaters Private Limited, a wholly owned subsidiary of Valencia Nutrition Limited, has entered into a strategic manufacturing agreement with Virchow Laboratories Limited for the production of its juice product portfolio. The deal, announced on April 6, 2026, covers 8 SKUs across key fruit variants and is aimed at accelerating production efficiency and expanding Valencia’s market presence.
Valencia Beverages and Superwaters Private Limited, which is a part of Valencia Nutrition Limited signed an agreement with Virchow Laboratories Limited to make its juice products. This deal was announced on April 6 2026.
It is for 8 different kinds of juices including Mango, Guava, Apple and others. The goal of this deal is to make production more efficient and help Valencia Nutrition Limited reach people.
Valencia Beverages and Superwaters Private Limited signed a manufacturing agreement with Virchow Laboratories Limited. Virchow Laboratories will make Valencia’s juice products, which include 8 kinds of juices. This agreement means that Virchow Laboratories will produce an amount of juice every month, which is about 15% of what Valencia’s Unit II facility in Hyderabad can make.
The partnership is positioned as a capacity and efficiency play, with Valencia looking to leverage Virchow Laboratories’ organisational strength to shorten its learning curve in beverage production while meeting growing consumer demand. The deal is also expected to drive optimal utilisation of the Hyderabad plant, which has historically operated below full capacity.
Valencia Nutrition Limited’s stock was trading at Rs 51.40 on April 7, 2026, up 9.36% against its previous close of Rs 47.00, with a market capitalisation of approx Rs 88.56 crore. The stock’s 52-week high stands at Rs 97.10 against a low of Rs 44.18, reflecting a stock that remains significantly off its peak. The day’s uptick appears to be a direct market reaction to the manufacturing agreement announced with Virchow Laboratories on April 6, 2026.
About the Company
Valencia Nutrition Limited was started in April 2013. Makes nutrition and beverage products. It has two plants in Hyderabad. Works with other manufacturers in South India. Virchow Laboratories Limited is a pharmaceutical company that makes a lot of medicine. It is the producer of Sulfamethoxazole in the world and works with big companies like GlaxoSmithKline.
This deal is important for Valencia Nutrition Limited because it wants to grow its beverage business. The company wants to work with partners to make its products and this deal is a step in that direction. Investors will be watching to see if this deal helps Valencia Nutrition Limited make money in the future.
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
The post Valencia Nutrition Jumps Over 9% After Subsidiary Signs Manufacturing Deal with Virchow appeared first on Trade Brains.
What's Your Reaction?
